Yancheng Suhai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding US DMF Number 36491.
Remarkably, this DMF maintains an Active status since its submission on November 11, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 16, 2022, and payment made on September 29, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II